Skip to main content
Clinical Trials/NCT06598423
NCT06598423
Recruiting
Not Applicable

Pilot Test of a Novel Wavelength-Based Method to Control Childhood Myopia

University of Alabama at Birmingham1 site in 1 country80 target enrollmentApril 10, 2025
ConditionsMyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
University of Alabama at Birmingham
Enrollment
80
Locations
1
Primary Endpoint
Change in cycloplegic spherical equivalent refractive error
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

The goal of this clinical trial is to learn if daily brief periods of specialized soft contact lens wear work to slow the progression of nearsightedness in children. Additionally, the study will learn about the compliance and safety of specialized soft contact lens wear in children. The main questions it aims to answer are:

Does wearing specialized soft contact lenses daily slow myopia progression and axial elongation? What visual/ocular problems do participants have when wearing specialized soft contact lenses? Researchers will compare two soft contact lenses to see if specialized soft contact lens wear works to treat childhood myopia progression.

Participants will

  1. Wear either a single type of soft contact lens or two types of soft contact lenses at alternate times daily full time in both eyes for one year.
  2. Visit the clinic at 2 weeks, 1 month, 3 months, 6 months, and 12 months for checkups and tests
  3. Keep a diary of the lens-wearing times.

Detailed Description

Myopia (nearsightedness) is a major public health concern. The prevalence of myopia continues to rise globally, including in the United States. Myopia develops when the eye grows excessively long for its optics, producing out-of-focus images of distant objects on the retina. Blurry distant vision in myopia can be easily corrected by traditional optical and surgical means. However, these methods do nothing to slow myopia-associated excessive axial elongation of the eye which is a major risk factor for several sight-threatening ocular pathologies, such as myopia maculopathy and retinal detachment later in life. Interventions to slow axial elongation and therefore myopia will have a significant public health benefit. This randomized controlled clinical trial will test the efficacy of wearing specialized soft contact lenses in slowing the progression of myopia in children. In this pilot trial, children with myopia will wear daily use, daily disposable, single-vision soft contact lenses in both eyes for one year. One group will wear a single type of soft contact lens full-time daily whereas the other group will wear two types of soft contact lenses daily at alternate times. The two lenses are identical in material, comfort, and lens geometry and different only in their spectral profile.

Registry
clinicaltrials.gov
Start Date
April 10, 2025
End Date
July 31, 2027
Last Updated
6 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Safal Khanal

Assistant Professor

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Spherical component of refractive error in primary meridian between -0.75 and -5.00 D
  • Less than 1.00 D of astigmatism or anisometropia
  • History of soft contact lens wear for at least a week
  • Best-corrected visual acuity of 20/25 (+0.10 logMAR) or better in each eye
  • Willingness to wear the lenses for a minimum of 10 hours/day, at least six days a week for the duration of the study

Exclusion Criteria

  • Subjects receiving myopia control treatments within the past six months
  • History of premature (less than 3.3 lb) or preterm birth (earlier than 30 weeks)
  • Current history of using systemic or ocular medications (including artificial tears) that may affect contact lens wear, tear film health, refractive state, pupillary response or accommodative function
  • History of ocular or systemic diseases, including those that may affect refractive development
  • Known allergy to fluorescein, benoxinate, proparacaine, or tropicamide
  • Contact lens contraindications (e.g., giant papillary keratoconjunctivitis)
  • Corneal disorders (e.g., hypoesthesia, keratoconus)
  • Strabismus at distance or near with distance glasses or contact lenses
  • Subjects exhibiting poor personal hygiene that may affect the compliance of contact lens wear.

Outcomes

Primary Outcomes

Change in cycloplegic spherical equivalent refractive error

Time Frame: Baseline and 12 months

Cycloplegic autorefraction measurements will be recorded using the WAM 5500 autorefractor in both eyes at baseline and follow-up visits. A set of 10 spherical equivalent measures will be obtained in each eye and later averaged to obtain the eye's final refractive error.

Change in axial length

Time Frame: Baseline and 12 months

Ocular component dimensions, including axial length, will be recorded using the Haag-Streit LenStar LS900 based on low-coherence interferometry. A set of five measurements in primary gaze in each eye will be averaged to obtain the final dimension of the ocular components.

Secondary Outcomes

  • Change in choroidal thickness(Baseline and 12 months)
  • Change in visual acuity(Baseline and 12 months)
  • Change in accommodative response(Baseline and 12 months)

Study Sites (1)

Loading locations...

Similar Trials